Proprietario: Centro di Riferimento Oncologico di Aviano

Method for the production of an IgM antibody for diagnosis and treatment of tumors expressing the tumor-associated antigen Glypican-1 (GPC1).

Substrate production process and predictive model, based on spectral data, to carry out biofluid samples analysis.

Method to measure the concentration of the drug Imatinib in patient's plasma and then to establish the optimal dose for his therapy.

Method for the real time measure of Irinotecan drug's concentration in patient's plasma and then to establish the optimal dose for the therapy.

Copper nitroprusside-based nanomaterial to be used in cancer treatment, it is able to generate ROS in tumor cell lines.

Micro-fluidic device that performs precise volumetric analyses of the process of clot formation in a blood sample under laminar flow conditions.

Chromatographic system modification that allows to speed up processes as pharmacological monitoring through mass spectrometry.

Solution which allows to discriminate responders and non responders patients to platinum based therapy allowing to personalize treatment.

Targeted release of molecules with therapeutic action based on adipose stromal stem cells obtained through ex-vivo expansion.